CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net earnings (loss)	$ 22,032	$ (79,591)	$ (52,767)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
Stock-based compensation expense	12,042	64,340	44,893
Amortization of intangibles	2,839	5,100	5,846
Depreciation	1,997	2,198	923
Provision for credit losses	777	7,606	1,428
(Gain) loss on the sale of an asset	37	0	(10,151)
Non-cash lease expense	4,449	5,971	3,884
Other adjustments, net	1,333	(433)	542
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable	1,075	(13,027)	(19,204)
Prepaid expenses and other assets	(5,180)	(3,090)	(10,086)
Accounts payable and other liabilities	(7,744)	(23,760)	13,948
Deferred revenue	4,128	(2,385)	36,698
Net cash provided by (used in) operating activities	37,785	(37,071)	15,954
Cash flows from investing activities:
Acquisitions, net of cash acquired	0	21	(14,241)
Capital expenditures	(108)	(802)	(445)
Proceeds from the sale of an asset	639	1,611	7,862
Net cash provided by (used in) investing activities	531	830	(6,824)
Cash flows from financing activities:
Proceeds from sale of common stock, net of fees	0	0	299,750
Principal payments on related-party debt	0	0	(94,565)
Deferred financing costs	0	0	(1,440)
Amounts related to settlement of equity awards	(6,414)	(5,448)	(4,051)
Proceeds from exercise of stock options	759	18	3,364
Contingent consideration payment	(5,774)	(4,816)	0
Other, net	(266)	(342)	0
Net cash (used in) provided by financing activities	(11,695)	(10,588)	203,058
Total cash provided (used)	26,621	(46,829)	212,188
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(19)	(682)	120
Net increase (decrease) in cash and cash equivalents and restricted cash	26,602	(47,511)	212,308
Cash and cash equivalents and restricted cash at beginning of period	274,834	322,345	110,037
Cash and cash equivalents and restricted cash at end of period	$ 301,436	$ 274,834	$ 322,345